OPKO Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on April 30, 2008, reporting events that occurred on April 28, 2008. The filing addresses compensation matters reviewed by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock option exercise price of $1.65 per share, based on the closing price on the American Stock Exchange on April 28, 2008.
Material Changes and Compensation Actions
- Stock Option Grants: The Compensation Committee granted stock options to four executive officers effective April 28, 2008:
- Phillip Frost, M.D. (CEO and Chairman): 300,000 shares
- Jane Hsiao, Ph.D. (Vice Chairman and CTO): 250,000 shares
- Steven D. Rubin (EVP - Administration): 200,000 shares
- Rao Uppaluri, Ph.D. (SVP and CFO): 175,000 shares
- Salary and Bonus Decisions: The Committee determined not to increase base salaries from 2007 levels. Additionally, no annual cash bonus will be paid for the fiscal year ended December 31, 2007.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of specific risks and contingencies beyond the standard disclosure of the compensation decisions.
Key Facts for Investor Verification
- Verify the total number of shares authorized for issuance under the Company's stock option plan to ensure these grants are within limits.
- Confirm the impact of the $1.65 exercise price relative to the current market price of OPKO Health stock.
- Review the Company's cash position given the decision to forego annual cash bonuses for the 2007 fiscal year.
- Check subsequent filings for any changes to the base salary levels or bonus structures for the current fiscal year.